✦ LIBER ✦

Cost Utility Analysis of Everolimus in the Treatment of Metastatic Renal Cell Cancer in the Netherlands

✍ Scribed by Mihajlović, J.; Minović, I.; Bruinsma, A.; Postma, M.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN101 Cost Effectiveness of Everolimus

✍ J. Mihajlović; P. Pechlivanoglou; A. Sabo; Z. Tomić; M.J. Postma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

A Cost-Utility Analysis of Everolimus Pl

✍ Taylor, M.; Lewis, L.; Vieira, J.; Chandiwana, D. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Effectiveness of Everolimus for Sec

✍ Mihajlović, Jovan; Pechlivanoglou, Petros; Sabo, Ana; Tomić, Zdenko; Postma, Maa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 284 KB

CN2 COST-UTILITY ANALYSIS OF LHRH AGONIS

✍ M Hemels; M Iskedjian; N Iscoe; N Fleshner; T Einarson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN30 A COST—UTILITY ANALYSIS MODEL FOR

✍ I Contreras-Hernandez; J Mould-Quevedo; G Salinas-Escudero; J Tapia-Valencia; G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Second-line everolimus treatment in adva

✍ Vicki Brower 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 57 KB